Have a symptom?
See what questions
a doctor would ask.
News » Baby’s survival rate reduced by late diagnosis of SCID

Baby’s survival rate reduced by late diagnosis of SCID

A baby boy wasn’t diagnosed with SCID until he was 51/2 months old. If babies are diagnosed before 3 months, their rate of survival after bone marrow transplant is 97%. If diagnosed after 3 months the rate falls to 69%.

Source: summary of medical news story as reported by Scien Central News

Related Disease Topics:

Article Source Details

About: Baby’s survival rate reduced by late diagnosis of SCID

Date: 30 May 2004

Source: Scien Central News

Author: Karen Lurie


Related Medical Topics

This summary article refers to the following medical categories:

More News Topics

  • Confidential settlement over elderly woman’s death
  • Conflict over pros and cons of Vioxx
  • Congenital second hand smoke risks lung disease
  • Connective tissue disease frequently misdiagnosed or undiagnosed
  • Constipation misdiagnosis leads to woman's death
  • Consuming diet and thyroid pills during pregnancy may increase incidence of homosexual offspring
  • Continual food allergy testing necessary for children
  • Contraceptive patch attacked by media
  • Control of blood pressure improves memory
  • COPD and beneficial use of inhaled steroids
  • COPD improved with cholesterol lowering agent
  • COPD increasingly threatens world populations
  • COPD is Australia 4th highest killer
  • COPD is the 4th leading killer but there is not much awareness of the condition

    By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.

    Home | Symptoms | Diseases | Diagnosis | Videos | Tools | Forum | About Us | Terms of Use | Privacy Policy | Site Map | Advertise